Loading...

EWTX EDGEWISE THERAPEUTICS INC Management Changes 8-K Filing

DGWS

WTX

EDGEWISE THERAPEUTICS INC

(EWTX)

2023 8-K

Financial Results Released

Director Appointment

Management Change

Financial Results Announcement

Financial Statements

Product Expansion

Financial Statements

Positive Trial Results

Financial Results

Management Change

Positive Trial Results

Q3 Financial Results

Equity Incentive Plan

Earnings Report

Amendment to Certificate of...

Sales Agreement with Leerin...

Financial Results Announcement

Appointment of Director

Financial Results Announcement

Underwriting Agreement

Financial Information and M...

Earnings Reports

Earnings Reports

Sales Agreement with BofA S...

Earnings Reports

Appointment of Director

Financial Results Announcement

External Links:

Edgewise Therapeutics appointed Dr. Jonathan Fox as a Class III director and member of the Nominating and Corporate Governance Committee, with compensation and stock options.

AI Assistant

EDGEWISE THERAPEUTICS INC

2023

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.